MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, FOLD made $634,210K in revenue. -$27,110K in net income. Net profit margin of -4.27%.

Income Overview

Revenue
$634,210K
Net Income
-$27,110K
Net Profit Margin
-4.27%
EPS
-$0.09
Unit: Thousand (K) dollars
Revenue Breakdown
    • Galafold
    • Pombiliti Opfolda

Income Statement
2025-12-31
Net product sales
634,210
Cost of goods sold
72,929
Gross profit
561,281
Research and development
135,843
Selling, general, and administrative
383,487
Changes in fair value of contingent consideration payable
0
Loss on impairment of assets
1,702
Restructuring charges
0
Depreciation and amortization
7,460
Total operating expenses
528,492
Income (loss) from operations
32,789
Interest income
3,317
Interest expense
46,159
Loss on extinguishment of debt
0
Other (expense) income
10,244
Income (loss) before income tax
191
Income tax expense
27,301
Net loss attributable to common stockholders
-27,110
Basic EPS
-0.09
Diluted EPS
-0.09
Basic Average Shares
308,363,768
Diluted Average Shares
308,363,768
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Non Us$305,941K US$215,761K Non Us$64,243K US$48,265K Galafold$521,702K Pombiliti Opfolda$112,508K Net product sales$634,210K Gross profit$561,281K Cost of goods sold$72,929K Income (loss) fromoperations$32,789K Other (expense)income$10,244K Interest income$3,317K Total operatingexpenses$528,492K Net lossattributable to common...-$27,110K Income (loss) beforeincome tax$191K Interest expense$46,159K Selling, general, andadministrative$383,487K Research and development$135,843K Depreciation andamortization$7,460K Loss on impairment ofassets$1,702K Income tax expense$27,301K

logosdsadsad-svg

AMICUS THERAPEUTICS, INC. (FOLD)

logosdsadsad-svg

AMICUS THERAPEUTICS, INC. (FOLD)